Jeanne Hecht

Company: Lexitas Pharma Services

Job title: CEO & Chairwoman of the Board

Seminars:

Investor Panel: Funding Retinal Innovation — Strategies to Advance Dry AMD & GA Therapies from Discovery to Clinic 1:45 pm

Explore how investors evaluate early-stage retinal programs with novel mechanisms targeting dry AMD and GA Discuss key data inflection points (preclinical validation, safety studies, early efficacy signals, regulatory alignment) that attract venture and institutional funding Review challenges specific to funding AMD programs including long development timelines, endpoint complexity, and patient heterogeneityRead more

day: Day2